Literature DB >> 30293148

The most recent concepts for the management of bacterial and fungal infections in ICU.

Matteo Bassetti1,2, Garyfallia Poulakou3, Marin H Kollef4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30293148     DOI： 10.1007/s00134-018-5400-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  19 in total

Review 1.  Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis.

Authors:  Elena Carrara; Iris Pfeffer; Oren Zusman; Leonard Leibovici; Mical Paul
Journal:  Int J Antimicrob Agents       Date:  2017-12-23       Impact factor: 5.283

2.  Understanding biofilm formation in intravascular device-related infections.

Authors:  Christophe Beloin; Nuria Fernández-Hidalgo; David Lebeaux
Journal:  Intensive Care Med       Date:  2016-08-06       Impact factor: 17.440

3.  Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.

Authors:  Sébastien Bailly; Olivier Leroy; Philippe Montravers; Jean-Michel Constantin; Hervé Dupont; Didier Guillemot; Olivier Lortholary; Jean-Paul Mira; Pierre-François Perrigault; Jean-Pierre Gangneux; Elie Azoulay; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2015-09-14       Impact factor: 17.440

4.  Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.

Authors:  Jan J De Waele; Murat Akova; Massimo Antonelli; Rafael Canton; Jean Carlet; Daniel De Backer; George Dimopoulos; José Garnacho-Montero; Jozef Kesecioglu; Jeffrey Lipman; Mervyn Mer; José-Artur Paiva; Mario Poljak; Jason A Roberts; Jesus Rodriguez Bano; Jean-François Timsit; Jean-Ralph Zahar; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2017-12-29       Impact factor: 17.440

Review 5.  Intensive care medicine research agenda on invasive fungal infection in critically ill patients.

Authors:  Matteo Bassetti; Jose Garnacho-Montero; Thierry Calandra; Bartjan Kullberg; George Dimopoulos; Elie Azoulay; Arunaloke Chakrabarti; Daniel Kett; Cristobal Leon; Luis Ostrosky-Zeichner; Maurizio Sanguinetti; Jean-Francois Timsit; Malcom D Richardson; Andrew Shorr; Oliver A Cornely
Journal:  Intensive Care Med       Date:  2017-03-02       Impact factor: 17.440

6.  Incidence, characteristics and outcome of ICU-acquired candidemia in India.

Authors:  Arunaloke Chakrabarti; Prashant Sood; Shivaprakash M Rudramurthy; Sharon Chen; Harsimran Kaur; Malini Capoor; Deepinder Chhina; Ratna Rao; Vandana Kalwaje Eshwara; Immaculata Xess; Anupama J Kindo; P Umabala; Jayanthi Savio; Atul Patel; Ujjwayini Ray; Sangeetha Mohan; Ranganathan Iyer; Jagdish Chander; Anita Arora; Raman Sardana; Indranil Roy; B Appalaraju; Ajanta Sharma; Anjali Shetty; Neelam Khanna; Rungmei Marak; Sanjay Biswas; Shukla Das; B N Harish; Sangeeta Joshi; Deepak Mendiratta
Journal:  Intensive Care Med       Date:  2014-12-16       Impact factor: 17.440

Review 7.  Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Authors:  Matteo Bassetti; Garyphallia Poulakou; Etienne Ruppe; Emilio Bouza; Sebastian J Van Hal; Adrian Brink
Journal:  Intensive Care Med       Date:  2017-07-21       Impact factor: 17.440

8.  Use of Implementation Science for a Sustained Reduction of Central-Line-Associated Bloodstream Infections in a High-Volume, Regional Burn Unit.

Authors:  Geeta Sood; Julie Caffrey; Kelly Krout; Zeina Khouri-Stevens; Kevin Gerold; Stefan Riedel; Janet McIntyre; Lisa L Maragakis; Renee Blanding; Jonathan Zenilman; Richard Bennett; Peter Pronovost
Journal:  Infect Control Hosp Epidemiol       Date:  2017-09-13       Impact factor: 3.254

9.  Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.

Authors:  Patrick N A Harris; Paul A Tambyah; David C Lye; Yin Mo; Tau H Lee; Mesut Yilmaz; Thamer H Alenazi; Yaseen Arabi; Marco Falcone; Matteo Bassetti; Elda Righi; Benjamin A Rogers; Souha Kanj; Hasan Bhally; Jon Iredell; Marc Mendelson; Tom H Boyles; David Looke; Spiros Miyakis; Genevieve Walls; Mohammed Al Khamis; Ahmed Zikri; Amy Crowe; Paul Ingram; Nick Daneman; Paul Griffin; Eugene Athan; Penelope Lorenc; Peter Baker; Leah Roberts; Scott A Beatson; Anton Y Peleg; Tiffany Harris-Brown; David L Paterson
Journal:  JAMA       Date:  2018-09-11       Impact factor: 56.272

10.  Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.

Authors:  Emmanuelle Cambau; Isabelle Durand-Zaleski; Stéphane Bretagne; Christian Brun-Buisson; Catherine Cordonnier; Xavier Duval; Stéphanie Herwegh; Julien Pottecher; René Courcol; Sylvie Bastuji-Garin
Journal:  Intensive Care Med       Date:  2017-04-03       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.